FI944905A7 - Endoteliiniantagonistit II - Google Patents

Endoteliiniantagonistit II Download PDF

Info

Publication number: FI944905A7
Authority: FI; Finland
Prior art keywords: endothelin; antagonists
Prior art date: 1992-04-22

Application number

FI944905A

Other languages

English (en)

Swedish (sv)

Other versions

FI944905A0 (fi

FI944905L (fi

Inventor

Wayne Livingston Cody

John Gordon Topliss

Annette Marian Doherty

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-22

Filing date

1993-04-16

Publication date

1994-10-19

1993-04-16 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1994-10-19 Publication of FI944905A0 publication Critical patent/FI944905A0/fi

1994-10-19 Publication of FI944905A7 publication Critical patent/FI944905A7/fi

1994-10-19 Publication of FI944905L publication Critical patent/FI944905L/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Reproductive Health (AREA)
Neurosurgery (AREA)

FI944905A 1992-04-22 1993-04-16 Endoteliiniantagonistit II FI944905L (fi)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US87222592A	1992-04-22	1992-04-22
US3351593A	1993-03-31	1993-03-31
PCT/US1993/003658 WO1993021219A1 (en)	1992-04-22	1993-04-16	Endothelin antagonists ii

Publications (3)

Publication Number	Publication Date
FI944905A0 FI944905A0 (fi)	1994-10-19
FI944905A7 true FI944905A7 (fi)	1994-10-19
FI944905L FI944905L (fi)	1994-10-19

Family

ID=26709808

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI944905A FI944905L (fi)	1992-04-22	1993-04-16	Endoteliiniantagonistit II

Country Status (12)

Country	Link
EP (1)	EP0647236A1 (fi)
JP (1)	JPH07505890A (fi)
KR (1)	KR950701344A (fi)
AU (1)	AU678357B2 (fi)
CA (1)	CA2133090A1 (fi)
CZ (1)	CZ256994A3 (fi)
FI (1)	FI944905L (fi)
HU (1)	HUT68862A (fi)
NO (1)	NO944013D0 (fi)
NZ (1)	NZ252855A (fi)
SK (1)	SK128794A3 (fi)
WO (1)	WO1993021219A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5382569A (en) *	1991-05-16	1995-01-17	Warner-Lambert Company	Endotherlin antagonists
US5550110A (en) *	1992-04-22	1996-08-27	Warner-Lambert Company	Endothelin Antagonists II
CA2121724A1 (en) *	1993-04-21	1994-10-22	Toshifumi Watanabe	Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
US5573762A (en) *	1995-04-24	1996-11-12	Genentech, Inc.	Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
UA58494C2 (uk) *	1995-06-07	2003-08-15	Зенека Лімітед	Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
US5688499A (en)	1996-03-13	1997-11-18	Queen's University At Kingston	Antagonism of endothelin actions
WO1998011913A1 (en) *	1996-09-16	1998-03-26	Dalhousie University	Use of igf-i for the treatment of polycystic kidney disease and related indications
US6030975A (en) *	1997-03-14	2000-02-29	Basf Aktiengesellschaft	Carboxylic acid derivatives, their preparation and use in treating cancer

1993
- 1993-04-16 CZ CZ942569A patent/CZ256994A3/cs unknown
- 1993-04-16 EP EP93912310A patent/EP0647236A1/en not_active Withdrawn
- 1993-04-16 NZ NZ252855A patent/NZ252855A/en unknown
- 1993-04-16 KR KR1019940703745A patent/KR950701344A/ko not_active Withdrawn
- 1993-04-16 CA CA002133090A patent/CA2133090A1/en not_active Abandoned
- 1993-04-16 JP JP5518657A patent/JPH07505890A/ja active Pending
- 1993-04-16 AU AU42904/93A patent/AU678357B2/en not_active Ceased
- 1993-04-16 SK SK1287-94A patent/SK128794A3/sk unknown
- 1993-04-16 FI FI944905A patent/FI944905L/fi unknown
- 1993-04-16 HU HU9403017A patent/HUT68862A/hu unknown
- 1993-04-16 WO PCT/US1993/003658 patent/WO1993021219A1/en not_active Ceased
1994
- 1994-10-21 NO NO944013A patent/NO944013D0/no unknown

Also Published As

Publication number	Publication date
AU4290493A (en)	1993-11-18
HUT68862A (en)	1995-08-28
NO944013L (no)	1994-10-21
FI944905A0 (fi)	1994-10-19
EP0647236A1 (en)	1995-04-12
AU678357B2 (en)	1997-05-29
SK128794A3 (en)	1995-03-08
NZ252855A (en)	1996-11-26
CA2133090A1 (en)	1993-10-28
HU9403017D0 (en)	1994-12-28
CZ256994A3 (en)	1995-02-15
WO1993021219A1 (en)	1993-10-28
JPH07505890A (ja)	1995-06-29
NO944013D0 (no)	1994-10-21
FI944905L (fi)	1994-10-19
KR950701344A (ko)	1995-03-23

Publication	Publication Date	Title
FI930774A7 (fi)	1993-08-25	Endoteliinin sufonamidiantagonistit
DE69327720D1 (de)	2000-03-02	Endothelin rezeptor antagonisten
FI961804A7 (fi)	1996-04-30	Endoteliinireseptoriantagonistit
FI932518A7 (fi)	1993-12-04	Angiotensiinin II antagonistit
NO943190D0 (no)	1994-08-29	Sulfonamid-endothelin-antagonister
ATE205711T1 (de)	2001-10-15	Endothelin-rezeptor-antagonisten
FI932517A7 (fi)	1993-12-04	Angiotensiinin II antagonistit
FI924397L (fi)	1993-04-25	Substituerade pyrimidiner
FI934300A7 (fi)	1993-10-20	Bradykiniiniantagonisteja
NO960473L (no)	1996-08-07	Substituerte bifenyl-sulfonamid-endotelin-antagonister
DK0699069T3 (da)	2002-05-27	Endothelinreceptorantagonister
ATE172738T1 (de)	1998-11-15	Substituierte 6-aza-androstenone
NO952289D0 (no)	1995-06-09	Substituerte benzazepinoner
NO944013D0 (no)	1994-10-21	Endothelin-antagonister II
DE59309389D1 (de)	1999-04-01	Substituierte Thiophencarbonsäureamide
FI930108A0 (fi)	1993-01-12	Imidazopyridin-paf-antagonister
DE59310082D1 (de)	2000-09-07	Substituierte 2-arylpyrrole
FI98103B (fi)	1996-12-31	Stallarakenne
NO923060D0 (no)	1992-08-03	Konstruksjonsmateriale
DK97492D0 (da)	1992-07-30	Naboalarm - 92
SE9203266D0 (sv)	1992-11-03	Chamotteroster/tegel